Micromedex Introduces AI-Powered Search for Clinical Decision Support

September 23, 2025
Micromedex has launched an AI-powered search tool to enhance clinical decision support for healthcare professionals, providing quick access to drug and toxicology information.

Micromedex has launched an AI-powered search tool designed to enhance clinical decision support for healthcare professionals, announced in a press release. This new feature allows clinicians to quickly access drug and toxicology information, including drug interactions, IV compatibility, and dosing calculations, by asking specific questions.

The AI-powered search is purpose-built for drug content, offering precise access to expertly curated information tailored to healthcare professionals' needs. It underwent a rigorous three-pronged clinical validation process, including internal testing, external validation by practicing clinicians, and real-world testing in clinical settings.

Several clients have already adopted the Micromedex AI technology, highlighting its ability to deliver fast, evidence-based insights and user-friendly features that enhance clinical decision support. This launch marks a significant milestone in Micromedex's ongoing commitment to innovation and improving the user experience for healthcare providers.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more